Extrachromosomal DNA (ecDNA) drives hepatocellular carcinoma malignancy through high-copy amplification of chromosome 1q21-derived PIP5K1A oncogene
Authors:
- 25 August 2025
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 633, 218004
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2022MH319)
- Natural Science Foundation of Shandong Province (ZR2022LZY027)
- Medical and Health Science and Technology Development Project of Shandong Province (202403031145)
This publication has 48 references indexed in Scilit:
- ATF7IP inhibits Sorafenib-induced ferroptosis in hepatocellular carcinoma cells by inhibiting CYB5R2 transcription and stabilizing PARK7 proteinRedox Biology, 2025
- Rupatadine inhibits colorectal cancer cell proliferation through the PIP5K1A/Akt/CDK2 pathwayBiomedicine & Pharmacotherapy, 2024
- Polyphyllin I ameliorates gefitinib resistance and inhibits the VEGF/VEGFR2/p38 pathway by targeting HIF-1a in lung adenocarcinomaPhytomedicine, 2024
- The role of PIP5K1A in cancer development and progressionMedical Oncology, 2022
- Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneityNature, 2017
- Production of Extrachromosomal MicroDNAs Is Linked to Mismatch Repair Pathways and Transcriptional ActivityCell Reports, 2015
- Assessment of chromosomal losses and gains in hepatocellular carcinomaCancer Letters, 2002
- Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridizationGenes, Chromosomes and Cancer, 2000
- Assessment of Genetic Changes in Hepatocellular Carcinoma by Comparative Genomic Hybridization AnalysisThe American Journal of Pathology, 1999
- Extrachromosomal circular DNAs and genomic sequence plasticity in eukaryotic cellsMutation Research/DNAging, 1990